Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

GeneDx Holdings (WGS) Other Gross PP&E Adjustments (2020 - 2026)

GeneDx Holdings has reported Other Gross PP&E Adjustments over the past 7 years, most recently at $43.8 million for Q1 2026.

  • Quarterly Other Gross PP&E Adjustments rose 29.64% to $43.8 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $43.8 million through Mar 2026, up 29.64% year-over-year, with the annual reading at $42.9 million for FY2025, 71.88% up from the prior year.
  • Other Gross PP&E Adjustments was $43.8 million for Q1 2026 at GeneDx Holdings, up from $42.9 million in the prior quarter.
  • Over five years, Other Gross PP&E Adjustments peaked at $128.1 million in Q2 2023 and troughed at $25.0 million in Q4 2024.
  • The 5-year median for Other Gross PP&E Adjustments is $57.1 million (2024), against an average of $72.5 million.
  • Year-over-year, Other Gross PP&E Adjustments crashed 63.15% in 2024 and then skyrocketed 71.88% in 2025.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at $106.8 million in 2022, then plummeted by 36.55% to $67.8 million in 2023, then crashed by 63.15% to $25.0 million in 2024, then skyrocketed by 71.88% to $42.9 million in 2025, then rose by 1.89% to $43.8 million in 2026.
  • Per Business Quant, the three most recent readings for WGS's Other Gross PP&E Adjustments are $43.8 million (Q1 2026), $42.9 million (Q4 2025), and $42.3 million (Q3 2025).